Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas - PubMed (original) (raw)

Affiliations

PMID: 9533549

Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas

T Vogt et al. Clin Cancer Res. 1998 Mar.

Abstract

The Lerks, ligands of eph-related receptor tyrosine kinases, are a rapidly expanding family of genes thought to play an important role in the development and oncogenesis of various tissues. However, very little experimental evidence supports this hypothesis. Using RNA fingerprinting, we detected increased expression of Lerk-5 mRNA in human melanocytes as a response to the tumor-promoting drug 12-O-tetradecanoylphorbol-13-acetate, which suggests a possible role of the Lerks in melanoma tumorigenesis and progression. Therefore, we studied Lerk-5 mRNA expression in various melanoma cell lines and tissues of melanocytic tumors by semiquantitative reverse transcription-PCR. Modest expression of Lerk-5 mRNA was found in two melanoma cell lines derived from early primary tumors (WM35 and WM1645B); two metastatic cell lines tested showed a 3.9-fold increased transcript abundance when compared to the primary cell lines (RPMI-7951 and SK-Mel5). Progeny of a melanoma cell line with very low Lerk-5 mRNA abundance (WM35) showed a 5-fold increase in Lerk-5 mRNA expression when it was selected for higher tumorigenicity and multicytokine resistance by passaging in nude mice or repeated high-dose UVB irradiation. Consistent with these experimental data, we found high levels of Lerk-5 mRNA expression in advanced primary malignant melanomas and metastases (n = 22) but significantly lower or undetectable mRNA expression in benign melanocytic nevi (n = 9; P < 0.001). We conclude that increased Lerk-5 expression possibly reflects or induces an increased potential of growth, tumorigenicity, and metastatic abilities in human melanomas. This makes the yet to be elucidated eph-related receptor tyrosine kinase/Lerk signaling system a potential new source for molecular markers as well as a target for new therapies.

PubMed Disclaimer

Cited by

EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion.
Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME. Nakada M, et al. Am J Pathol. 2005 Aug;167(2):565-76. doi: 10.1016/S0002-9440(10)62998-7. Am J Pathol. 2005. PMID: 16049340 Free PMC article.
Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma.
Bogenrieder T, Herlyn M. Bogenrieder T, et al. Crit Rev Oncol Hematol. 2002 Oct;44(1):1-15. doi: 10.1016/s1040-8428(01)00196-2. Crit Rev Oncol Hematol. 2002. PMID: 12398996 Free PMC article. Review.
[Role of receptor tyrosine kinase in the angiogenesis].
Meyer S, Hafner C, Vogt T. Meyer S, et al. Hautarzt. 2002 Sep;53(9):629-42. doi: 10.1007/s00105-002-0425-x. Hautarzt. 2002. PMID: 12432901 Review. German. No abstract available.
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Tang XX, Zhao H, Robinson ME, Cohen B, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE, Ikegaki N. Tang XX, et al. Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10936-41. doi: 10.1073/pnas.190123297. Proc Natl Acad Sci U S A. 2000. PMID: 10984508 Free PMC article.
The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion.
Nakada M, Anderson EM, Demuth T, Nakada S, Reavie LB, Drake KL, Hoelzinger DB, Berens ME. Nakada M, et al. Int J Cancer. 2010 Mar 1;126(5):1155-65. doi: 10.1002/ijc.24849. Int J Cancer. 2010. PMID: 19728339 Free PMC article.

Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas - PubMed (original) (raw)